Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients.
Related Articles
Cutting Edge
What can we learn from liquid biopsies?
Grandround
Optimising dose-dense regimens for early breast cancer
Senza categoria